The Effect of Perioperative Cardiac Output-guided GDT on Oxygen Delivery, Consumption, and Microcirculatory Perfusion
CUSTOM
1 other identifier
interventional
78
1 country
1
Brief Summary
Perioperative cardiac output-guided goal-directed therapy (GDT) triggers fluid, vasopressor, and inotrope administration assuming that optimizing cardiac output (i.e., global blood flow) ensures adequate oxygen delivery and microcirculatory perfusion - that are usually not directly monitored during goal-directed therapy. There is increasing evidence that perioperative cardiac output-guided goal-directed therapy may reduce postoperative complications compared to routine hemodynamic management in high-risk patients having major surgery. The effect of cardiac output-guided goal-directed therapy algorithms on perioperative oxygen delivery and consumption as well as microcirculatory perfusion, however, is unknown. The investigators aim to investigate the effect of using different cardiac output-guided goal-directed therapy algorithms on perioperative oxygen delivery and consumption as well as sublingual microcirculatory perfusion compared to routine perioperative hemodynamic management in patients having major abdominal surgery with general anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2021
CompletedFirst Submitted
Initial submission to the registry
August 29, 2021
CompletedFirst Posted
Study publicly available on registry
October 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2022
CompletedJune 30, 2022
June 1, 2022
10 months
August 29, 2021
June 29, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Perioperative changes in oxygen delivery
assessed via blood gas analysis
after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgery
Perioperative changes in oxygen consumption
assessed via indirect calorimetry
baseline awake, after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgery
Secondary Outcomes (2)
Perioperative changes of microcirculation
baseline awake, after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgery
Perioperative changes in cardiac output
baseline awake, after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgery
Other Outcomes (3)
Incidence of postoperative myocardial injury
baseline awake, within 6 hours after surgery, and on day 1, 2, and 3 after surgery
Incidence of acute kidney injury
baseline awake, within 6 hours after surgery, and on day 1, 2, and 3 after surgery
Perioperative changes in urethral perfusion index
after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgery
Study Arms (3)
Cardiac output maximization group
ACTIVE COMPARATORPatients will be treated according to a goal-directed therapy protocol aiming at a cardiac output maximization. Detailed protocol adapted from Edwards, M.R., et al., Optimisation of Perioperative Cardiovascular Management to Improve Surgical Outcome II (OPTIMISE II) trial: study protocol for a multicentre international trial of cardiac output-guided fluid therapy with low-dose inotrope infusion compared with usual care in patients undergoing major elective gastrointestinal surgery. BMJ Open, 2019. 9(1): p. e023455.
Cardiac output personalization group
ACTIVE COMPARATORPatients will be treated according to a goal-directed therapy protocol aiming at a personalized cardiac output goal determined with preoperative cardiac output assessment. Detailed protocol adapted from Nicklas, J.Y., et al., Personalised haemodynamic management targeting baseline cardiac index in high-risk patients undergoing major abdominal surgery: a randomised single-centre clinical trial. Br J Anaesth, 2020. 125(2): p. 122-132.
Routine management group
NO INTERVENTIONPatients will be treated according to routine hemodynamic management.
Interventions
Treatment algorithms targeting maximization or personalization of cardiac output
Eligibility Criteria
You may qualify if:
- Adult patients (≥18 years) having elective major abdominal surgery with general anesthesia
- Expected duration of surgery at least 120 minutes
- Planned postoperative monitoring in intensive care unit
You may not qualify if:
- Emergency surgery
- Age \<18 years
- Body weight \<50 kg
- Pregnancy
- Atrial fibrillation
- Planned patient positioning in other position than supine position
- Surgery within the last 30 days
- Inaccessibility of the head during surgery
- Peripheral artery disease stage ≥IIb
- Chronic vasculitis
- Supraglottic airway management
- Enterostomy repair surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Center Hamburg-Eppendorf
Hamburg, 20246, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Bernd Saugel, Prof., MD
The University Medical Center Hamburg-Eppendorf
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 29, 2021
First Posted
October 22, 2021
Study Start
August 1, 2021
Primary Completion
May 31, 2022
Study Completion
May 31, 2022
Last Updated
June 30, 2022
Record last verified: 2022-06